Design, Optimization, and Structural Characterization of an Apoptosis-Inducing Factor Peptide Targeting Human...

Area of Science:

• Neuroscience
• Biochemistry
• Structural Biology

Background:

• The interaction between apoptosis-inducing factor (AIF) and cyclophilin A (CypA) contributes to neuronal cell death.
• Inhibition of this interaction shows neuroprotective potential.

Purpose of the Study:

• To develop a more stable and effective peptide inhibitor of the AIF-CypA interaction.
• To characterize the structure and binding of a novel AIF-derived peptide.

Main Methods:

• Generation and purification of the AIF(381-389) peptide.
• Nuclear magnetic resonance (NMR) spectroscopy for structural determination (free and CypA-bound states).
• In vitro binding assays and cell-based anti-apoptotic activity assays.

Main Results:

• AIF(381-389) adopts a stable β-hairpin conformation.
• The peptide exhibits similar in vitro affinity for CypA but enhanced anti-apoptotic activity and proteolytic stability compared to AIF(370-394).
• An NMR-based 3D model of the complex revealed key binding interactions.

Conclusions:

• AIF(381-389) is a promising therapeutic lead for neuroprotection by inhibiting AIF-CypA interaction.
• The structural insights facilitate the design of improved AIF/CypA inhibitors with better pharmacokinetic properties.